The UCLA CARE Center is dedicated to finding new and improved ways to treat HIV and AIDS and help the body's immune system.
Intensive Monitored Antiretroviral Pause (IMAP)
The goal of the study is to collect information about what happens when people temporarily stop taking HIV medication while under close observation.
This study will test whether 4 infusions of drug called romidepsin will wake up the sleeping or hidden virus si it could be attacked by anti-HIV medications.
This study is for HIV-positive people who also have HIV-associated neorocognitive disorder (HAND). It will help us understand if adding maraviroc and/or dolutegravir to their current antiretroviral therapy will improve cognitive performance.
For more information about the UCLA CARE Center's clinical trials and research studies, please contact: